Katie Maass

4PUBLICATIONS
6CO-AUTHORS
Vision scienceInnate immunityPharmaceutical delivery technologiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 13, 2026
Ocular Half-Life: What it Does and Does Not Mean for Intravitreal Anti-angiogenic Drug Durability.

Robert Avery, Cheikh Diack, Nancy Holekamp

|Jan 18, 2023
International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs.

Ingrid M Pruimboom-Brees, Swati Gupta, Nagendra Chemuturi

|Sep 21, 2022
Leveraging patient-centric sampling for clinical drug development and decentralized clinical trials: Promise to reality.

Katie F Maass, Matthew D Barfield, Mototsugu Ito

|Nov 24, 2020
Will patient-centric sampling become the norm for clinical trials after COVID-19?

Christopher A James, Matthew D Barfield, Katie F Maass

Pageof 1